Block rallies after a 40% headcount cut, strong Q4 2025 results, and raised FY2026 guidance. Find out why I rate XYZ stock a buy.

Moderna has accused the FDA of moving the goal posts and being inconsistent with earlier advice. The FDA has refused to accept Moderna's marketing application of an mRNA-based seasonal influenza ...

House GOP leaders are trying to reinstate a prohibition on members calling snap votes to repeal President Trump’s tariffs through the end of July, setting up what will be a tricky House vote on ...

Ripple and XRPL contributors have outlined a growing set of “institutional DeFi” building blocks on the XRP Ledger that aim to make the network viable for regulated financial activity, per a Thursday ...